NewsRoom Articles - Page 34 of 46

WednesdayOct 19, 2022 11:15 am

Lexaria Bioscience Corp. (NASDAQ: LEXX) Using Novel DehydraTECH(TM) Technology to Address Unmet Antihypertension Drug Market

Research has shown that co-occurring conditions may be linked to high blood pressure, including bone aging and mental illness The antihypertension drug market is anticipated to rise due to the launch of novel pharmaceuticals and diagnostic agents Valued at US $30.2 billion in 2021, the market is expected to grow at a CAGR of 3%, resulting in a value of US $40 billion by 2031 Lexaria’s patented DehydraTECH(TM) technology offers higher bioavailability of active pharmaceutical ingredients due to, in part, bypassing first-pass-liver processing, improving the speed of onset, and brain absorption The American Heart Association (“AMA”) refers to high blood…

WednesdayOct 19, 2022 9:00 am

Flora Growth Corp. (NASDAQ: FLGC) Building Portfolio of Brands that Resonates with End Consumers as It Targets Margins and Profitability

Flora Growth is a global cannabis company building a connected, design-led collective of plant-based wellness and lifestyle brandsThe company’s portfolio of brands is designed to deliver the most compelling customer experiences in the worldThrough its M&A strategy, Flora Growth has brought on board brands like JustCBD, Vessel Brands Inc., Masaya, No Cap Hemp Co., and MambeFlora hopes to establish meaningful connections with consumers through these brands, which will enable it to increase its margins and profitability The cannabis industry has gone global, undergoing a sea change in commercialization, normalization, and liberalization. According to a report by New Frontier Data, this…

MondayOct 17, 2022 10:30 am

Golden Matrix Group Inc. (NASDAQ: GMGI) Thrives in an Industry Where Content is King

Google recently announced the closure of its Google Stadia gaming business, a decision which may have partly been underpinned by the dearth of new gaming titles available on the platformContent has remained a crucial driver of success within the iGaming industry, a factor which Golden Matrix Group have sought to cater toThrough their proprietary GM-X turnkey solution, the company provides its licensing partners with access to upward of 10,000 games drawn from over 25 gaming studios On November 19, 2019, Google made an announcement that was set to potentially change the face of the gaming universe as we know it.…

MondayOct 17, 2022 9:45 am

Lexaria Bioscience Corp.’s (NASDAQ: LEXX) Drug Development Program Seeking to Provide Safe, Well-Tolerated, Effective Antihypertensive Medication Amid Continued Reports of Suboptimal Adherence to Existing Treatments

Lexaria Bioscience, a global innovator in drug delivery technology, has developed a potential treatment for hypertension using the company’s patented DehydraTECH(TM) platform, now shown in several human studies to reduce blood pressure and arterial stiffnessLexaria’s antihypertensive drug development program comes at a time when researchers are documenting poor control of hypertension among both men and women, partly due to suboptimal adherence to existing antihypertension medicationReasons advanced for the suboptimal adherence include lack of awareness or treatment, increased number of prescribed medications, and major adverse effects of the prescribed drugsLexaria has so far shown that its DehydraTECH-CBD is not only effective…

MondayOct 17, 2022 9:00 am

Changing Legal Landscape for Cannabis in Colombia and the U.S. Portends a New Era of Productivity for Flora Growth Corp. (NASDAQ: FLGC)

Colombia and the United States have both recently exhibited new openness to the possibility of decriminalizing adult recreational cannabis use through legislative changeCannabis supplier Flora Growth cultivates its product at a key Colombian farm and provides it to international markets, and may see additional opportunities arise as cannabis policies advance in the two countriesFlora Growth recently announced completion of its first shipments of high-CBD dried cannabis flower to Switzerland and the Czech Republic, as well as CBD isolate supplied to its market in the United StatesThe company also recently reported a 604 percent YOY increase in revenues during the H1…

ThursdayOct 13, 2022 10:45 am

Pandemic, Dinosaurs and Raffles: Why Golden Matrix Group Inc. (NASDAQ: GMGI) is a Diamond in the Rough

While a tough economic climate has hurt many businesses in recent years, Golden Matrix has amassed a streak of 16 consecutive profitable quartersThe GMGI portfolio includes over 10,000 games and a turnkey system designed to promote user acquisition, engagement, retention, and monetizationAfter buying 80% of RKings International, GMGI is preparing to expand the business from its roots in the U.K. and Ireland into the Latin American markets The online gambling space is highly competitive, lending to most of the world’s biggest operators burning through tons of cash for marketing in a bid to try and attracts (and keep) customers. That’s…

ThursdayOct 13, 2022 9:00 am

Lexaria Bioscience Corp. (NASDAQ: LEXX) Using Patented DehydraTECH(TM) Technology to Fight America’s Silent Killer – Hypertension

Three out of four adults living with hypertension do not have the condition under control, putting them at risk for other serious complicationsLexaria’s proposed therapy for hypertension is the highly efficient DehydraTECH-CBD, which has presented with no serious adverse side effects in test participantsDominated by the North American market, the global antihypertension drug market accounted for $22,557 million in 2018 and is expected to reach $28,797 million by 2026 In the United States, over 121.5 million adults are affected by high blood pressure – with statistics stacked against people of color, those with a family history of high blood pressure,…

TuesdayOct 11, 2022 9:45 am

Lexaria Bioscience Corp. (NASDAQ: LEXX) Patented DehydraTECH(TM) Technology Offering Solutions to Growing Hypertension Problem Worldwide

Hypertension affects nearly half of all adults in the United States – 47% or 116 million people, some of which are medication-resistantA recent study from the University of Toledo College of Medicine and Life Sciences concluded gut bacteria might be the cause of medication-resistant hypertension – as demonstrated in rats used to conduct the studyLexaria’s patented DehydraTECH(TM) technology offers a viable solution for hypertension drug administration and has been received favorably by the FDA during a pre-Investigational New Drug meeting Hypertension, or high blood pressure, remains one of the world’s most deadly health problems, considered a silent killer because it…

MondayOct 10, 2022 11:15 am

Rosy Outlook for Global Cannabis Market Boosts Hopes for Flora Growth Corp. (NASDAQ: FLGC) as Supply Chain Expands

Cannabis grower and product maker Flora Growth is developing its own approach to riding troubling economic forces, boasting a 604 percent YOY increase in the H1 reporting period this yearMarket analysts predict the global cannabis market’s value will rise during the next five years at a CAGR of 24.3 percent to arrive at annual valuation of $82.3 billionFlora Growth is levying the potential of recent cooperative agreements to increase the reach of its product distribution pipeline, including new exports to Switzerland, the Czech Republic and the United StatesEurope is predicted to be the fastest-growing region for cannabis sales during the…

FridayOct 07, 2022 11:15 am

Lexaria Bioscience Corp. (NASDAQ: LEXX) Working to Address Declining Antihypertensive Intensification and High Prescription Abandonment Rates, with DehydraTECH-CBD

Lexaria is a global innovator in drug delivery platforms developing DehydraTECH-CBD as a potential treatment for hypertensionA 2022 study documented a decline in the percentage of patients receiving appropriate treatment intensification over the last ten yearsThis decline has been attributed to, among other possible reasons, the side effects of antihypertensive drugsAt the same time, only 24% of adults with hypertension have the condition under control, a statistic attributable to the medications’ troublesome side effectsLexaria’s investigations of its DehydraTECH-CBD have so far presented favorable safety and tolerability data, meaning its drug candidate could offer reprieve to millions looking for antihypertensive drugs…

Spotlighting undiscovered companies with enormous upside potential.

Contact us: (512) 354-7000